An endotoxin-induced serum factor that causes necrosis of tumors
- PMID: 1103152
- PMCID: PMC433057
- DOI: 10.1073/pnas.72.9.3666
An endotoxin-induced serum factor that causes necrosis of tumors
Abstract
In studying "hemorrhagic necrosis" of tumors produced by endotoxin, it was found that the serum of bacillus Calmette--Guerin (BCG)-infected mice treated with endotoxin contains a substance (tumor necrosis factor; TNF) which mimics the tumor necrotic action of endotoxin itself. TNF-positive serum is as effective as endotoxin itself in causing necrosis of the sarcoma Meth A and other transplanted tumors. A variety of tests indicate that TNF is not residual endotoxin, but a factor released from host cells, probably macrophages, by endotoxin. Corynebacteria and Zymosan, which like BCG induce hyperplasia of the reticulo-endothelial system, can substitute for BCG in priming mice for release of TNF by endotoxin. TNF is toxic in vitro for two neoplastic cell lines; it is not toxic for mouse embryo cultures. We propose that TNF mediates endotoxin-induced tumor necrosis, and that it may be responsible for the suppression of transformed cells by activated macrophages.
Similar articles
-
Endotoxin-induced tumor necrosis factor.Recent Results Cancer Res. 1980;75:207-12. doi: 10.1007/978-3-642-81491-4_32. Recent Results Cancer Res. 1980. PMID: 7232833
-
[Definition of tumor-necrosis factor and its production mechanism].Gan To Kagaku Ryoho. 1984 Jul;11(7):1356-68. Gan To Kagaku Ryoho. 1984. PMID: 6378100 Japanese.
-
Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma.Cancer Res. 1976 Sep;36(9 pt.1):3255-9. Cancer Res. 1976. PMID: 788897
-
Nonspecific immunotherapy of malignant tumors.Radiology. 1976 Jan;118(1):211-8. doi: 10.1148/118.1.211. Radiology. 1976. PMID: 1105663 Review.
-
Modulation of antitumor immunity--immunobiologic approaches.Springer Semin Immunopathol. 1982;5(2):193-220. doi: 10.1007/BF00199796. Springer Semin Immunopathol. 1982. PMID: 6293113 Review. No abstract available.
Cited by
-
Perspectives on Oncolytic Salmonella in Cancer Immunotherapy-A Promising Strategy.Front Immunol. 2021 Feb 25;12:615930. doi: 10.3389/fimmu.2021.615930. eCollection 2021. Front Immunol. 2021. PMID: 33717106 Free PMC article. Review.
-
Inflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells.PLoS One. 2012;7(10):e47440. doi: 10.1371/journal.pone.0047440. Epub 2012 Oct 15. PLoS One. 2012. PMID: 23077618 Free PMC article.
-
Current status of immunotherapy for the treatment of lung cancer.J Thorac Dis. 2010 Dec;2(4):237-44. doi: 10.3978/j.issn.2072-1439.2010.11.6. J Thorac Dis. 2010. PMID: 22263052 Free PMC article.
-
Lipopolysaccharide Cross-Tolerance Delays Platelet-Activating Factor-Induced Sudden Death in Swiss Albino Mice: Involvement of Cyclooxygenase in Cross-Tolerance.PLoS One. 2016 Apr 11;11(4):e0153282. doi: 10.1371/journal.pone.0153282. eCollection 2016. PLoS One. 2016. PMID: 27064683 Free PMC article.
-
Pro-tumorigenic role of type 2 diabetes-induced cellular senescence in colorectal cancer.Front Oncol. 2022 Aug 18;12:975644. doi: 10.3389/fonc.2022.975644. eCollection 2022. Front Oncol. 2022. PMID: 36059680 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical